Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, liver disorder, neoplasmRecruitingPhase 12026-09-22NCT06858813

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AbbVie340

22 results · Page 1 of 1

Swipe the table sideways for more columns.